Type 2 diabetes and obesity are now widely listed among risk factors for developing AD, now increasingly recognized as a metabolic disease, since patients display impaired brain glucose metabolism and insulin signaling [14], [15], [16]. This evidence concerns the gene INS and type 2 diabetes mellitus.